Total Transplants
587
across all organ programs
This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care.
Open-data reference.
New Jersey · Code: NJHK
Hackensack University Medical Center is a transplant program in New Jersey (SRTR center code NJHK). According to SRTR Program-Specific Reports from November 2025, the center operates 3 distinct organ programs — Kidney, Kidney-Pancreas, Pancreas. Each program is independently evaluated by the Scientific Registry of Transplant Recipients using risk-adjusted survival estimates, so performance on one organ does not imply performance on another.
Across all programs, the center reported approximately 587 transplant procedures during the most recent SRTR reporting cohort. An estimated 399 candidates sit on this center's combined waiting lists, though allocation is driven by OPTN policy (blood type, medical urgency, geography, organ-specific criteria) rather than list position alone. The strongest 1-year graft survival rate at this center is 100.0% for kidney-pancreas transplants, versus a risk-adjusted national benchmark of 94.9%.
1 of this center's 3 reporting programs meet or exceed the national 1-year graft survival benchmark. SRTR excludes programs below statistical volume thresholds, so some organs may show limited data. Use the table below to compare each organ program's survival, volume, and waitlist against national averages. This information is factual and does not constitute medical advice.
National median wait times from listing to transplant. Individual wait times vary by blood type, urgency, and geographic allocation region.
Total Transplants
587
across all organ programs
Programs Above Avg
1/3
at or above national 1yr survival
Best: 100.0% (Kidney-Pancreas)
Based on SRTR Program-Specific Reports (November 2025), Hackensack University Medical Center in New Jersey operates 3 transplant programs covering Kidney, Kidney-Pancreas, Pancreas. The center performed approximately 587 transplants during the most recent reporting period. There are currently an estimated 399 patients on its combined waiting lists.
1 of 3 organ programs at this center reports 1-year graft survival rates at or above the national average, according to SRTR risk-adjusted estimates. Outcomes may vary based on individual patient factors, and survival statistics alone do not determine the quality of a transplant program. Patients are encouraged to discuss these figures with their transplant team.
Source: Scientific Registry of Transplant Recipients (SRTR) Program-Specific Reports (CSRS 2511) · November 2025
| Organ | 1-yr Survival | 3-yr Survival | US Avg | Transplants | Waitlist |
|---|---|---|---|---|---|
| Kidney | 92.9% -2.1 | 85.3% | 95.0% | 569 | 383 |
| Kidney-Pancreas | 100.0% +5.1 | N/A | 94.9% | 13 | 12 |
| Pancreas | N/A | N/A | N/A | 5 | 4 |
Based on SRTR data from November 2025, Hackensack University Medical Center reports a 1-year graft survival rate of 100.0% for kidney-pancreas transplants, compared to a national average of 94.9%. Survival rates vary by organ type and may not predict individual outcomes. Discuss these statistics with your transplant team for guidance specific to your situation.
According to the latest SRTR data, Hackensack University Medical Center has approximately 399 patients on its combined transplant waiting lists across 3 organ programs. Wait times depend on many factors including organ type, blood type, medical urgency, and geographic allocation policies. Your transplant center can provide an estimated timeline based on your specific circumstances.
Hackensack University Medical Center offers transplant programs for Kidney, Kidney-Pancreas, Pancreas. Each program is independently evaluated by SRTR with its own survival rate data and volume statistics. Not all centers offer the same organ programs, so availability is an important factor when choosing a transplant center.
Hackensack University Medical Center has 1 of 3 organ programs performing at or above the national average 1-year graft survival rate. National rankings are based on SRTR risk-adjusted survival estimates and exclude centers with insufficient case volume. Rankings reflect statistical outcomes over a reporting period and should be considered alongside patient-specific factors such as geographic proximity, organ availability, and clinical expertise.
When evaluating Hackensack University Medical Center or any transplant center, consider multiple factors beyond survival statistics: the center's experience with your specific organ type, geographic proximity (which affects organ allocation timing), your insurance coverage, the multidisciplinary team's expertise, post-transplant follow-up capabilities, and the center's patient volume. SRTR data provides one lens, but the OPTN recommends discussing all options with your referring physician and potential transplant teams.
The data shown here comes from SRTR Program-Specific Reports released in November 2025 as part of the Collaborative Silo-Reservoir Study (CSRS). SRTR publishes updated program-specific reports approximately twice per year (typically May and November). Each release includes the most recent cohort data, which may lag by 6-18 months due to follow-up requirements for survival outcomes.
Explore additional healthcare resources for New Jersey from federal data sources.
Other transplant centers in New Jersey reporting to SRTR.
About This Data
This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care.
Source: Scientific Registry of Transplant Recipients (SRTR) Program-Specific Reports (CSRS 2511) · November 2025 Survival rates are 1-year graft survival estimates for adult recipients.
Read our methodology — how this data is sourced, computed, and verified.